CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation

Journal of Allergy and Clinical Immunology

Volumn 110, Issue 3, 2002, Pages 460-468

  Oh, Jae Won ^a   Seroogy, Christine M ^a   Meyer, Everett H ^a   Akbari, Omid ^a   Berry, Gerald ^a   Fathman, C G ^a   DeKruyff, Rosemarie H ^a   Umetsu, Dale T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Airway hyperreactivity; Asthma; IL 10; Regulatory cells

Indexed keywords

ALLERGEN; CD4 ANTIGEN; INTERLEUKIN 10;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; EFFECTOR CELL; HELPER CELL; IMMUNE RESPONSE; INFLAMMATORY CELL; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RESPIRATORY TRACT MUCOSA; T LYMPHOCYTE ACTIVATION;

EID: 0036736840     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.127512     Document Type: Article

References (49)

1. Umetsu DT, DeKruyff RH. Th1 and Th2 CD4+ cells in human allergic diseases. J Allergy Clin Immunol 1997;100:1-6.
2. Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-61.
3. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994;12:227-57.
4. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorden Science 1997;275:77-9.
5. Coffman RL, Varkila K, Scott P, Chatelain R. Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol Rev 1991;123:189-207.
6. Hansen G, Berry G, DeKruyff RH, Umetsu DT. Allergen-specific Thl cells fail to counterbalance Th2 cell-induced AHR but cause severe airway inflammation. J Clin Invest 1999;103:175-83.
7. Kitani A, Fuss IJ, Nakamura K, Schwartz OM, Usui T, Strober W. Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-betal plasmid: TGF-betal-mediated suppression of T helper cell type I response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation. J Exp Med 2000;192:41-52.
8. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
9. Crisi G, Santambrogio L, Hochwald GM, Smith SR, Carlino JA, Thorbecke GJ. Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-beta and interleukin-10. Eur J Immunol 1995;25:3035-40.
10. Xiao BG, Bai XF, Zhang GX, Link H. Suppression of acute and protracted-relapsing experimental allergic encephalomyelitis by nasal administration of low-dose IL-10 in rats. J Neuroimmunol 1998;84:230-7.
11. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
12. DeKruyff RH, Fang Y, Umetsu DT. Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting interleukin-12 production. J Immunol 1998;160:2231-7.
13. Macaulay AE, DeKruyff RH, Umetsu DT. Antigen-primed T cells from B cell-deficient JHD mice fail to provide B cell help. J Immunol 1998;160:1694-700.
14. Costa GL, Benson JM, Seroogy CM, Achacoso P, Fathman CG, Nolan GP. Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease. J Immunol 2000;164:3581-90.
15. Tsuyuki S, Stuyuki J, Einsle K, Kopf M, Coyle AJ. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal Th2 immune response and altered airway responsiveness. J Exp Med 1997;185:1671-9.
16. Murphy E, Shibuya K, Hosken N, et al. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J Exp Med 1996;183:901-13.
17. Hansen G, McIntire JJ, Yeung VP, et al. CD4+ Th cells engineered to produce latent TGF-b1 reverse allergen-induced airway hyperreactivity and inflammation. J Clin Invest 2000;11:89-96.
18. Varney VA, Hamid QA, Gaga M, et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993;92:644-51.
19. Gavett SH, O'Hearn DJ, Li X, Huang S-K, Finkelman PD, Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995;182:1527-36.
20. Kim TS, DeKruyff RH, Rupper R, Maecker HT, Levy S, Umetsu DT. An OVA-IL-12 fusion protein is more effective than OVA plus rIL-12 in inducing a Thl-dominated immune response and inhibiting antigen-specific IgE production. J Immunol 1997;158:4137-44.
21. Randolph DA, Carruthers CJ, Szabo SJ, Murphy KM, Chaplin DD. Modulation of airway inflammation by passive transfer of allergen-specific Thl and Th2 cells in a mouse model of asthma. J Immunol 1999;162:2375-83.
22. Hessel EM, Van Oosterhout AJ, Van Ark I, et al. Development of airway hyperresponsiveness is dependent on interferon-gamma and independent of eosinophil infiltration. Am J Respir Cell Mol Biol 1997;16:325-34.
23. Tsitoura DC, Blumenthal RL, Berry G, DeKruyff RH, Umetsu DT. Mechanisms preventing allergen-induced airways hyperreactivity: role of immune deviation and tolerance. J Allergy Clin Immunol 2000;106:239-46.
24. Robinson DS, Tsicopoulos A, Meng Q, Durham S, Kay AB, Hamid Q. Increased interleukin-10 messenger RNA expression in atopic allergy and asthma. Am J Respir Cell Mol Biol 1996;14:113-7.
25. Borish L. IL-10: evolving concepts. J Allergy Clin Immunol 1998;101:293-7.
26. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
27. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993;178:1041-8.
28. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993;151:1224-34.
29. Segal BM, Dwyer BK, Shevach EM. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med 1998;187:537-46.
30. van Scott MR JJ, Bradfield JF, Enright E, Sigounas A, Sur S. IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice. Am J Physiol Lung Cell Mol Physiol 2000;278:L667-74.
31. Makela MJ, Kanehiro A, Borish L, et al. IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc Natl Acad Sci 2000;97:6007-12.
32. Zuany-Amorim C, Haile S, Leduc D, et al. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest 1995;95:2644-51.
33. Stampfli MR, Cwiartka M, Gajewska BU, et al. Interleukin-10 gene transfer to the airway regulates allergic mucosal sensitization in mice. Am J Resp Cell Mol Biol 1999;21:586-96.
34. Tournoy KG, Kips JC, Pauwels RA. Endogenous interleukin-10 suppresses allergen-induced airway inflammation and nonspecific airway responsiveness. Clin Exp Allergy 2000;30:775-83.
35. Grunig G, Corry DB, Leach MW, Seymour BW, Kurup VP, Rennick DM. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 1997;185:1089-99.
36. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998;102:98-106.
37. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells secreting IL-10 mediate T cell tolerance induced by respiratory exposure to antigen. Nat Immunol 2001;2:725-31.
38. Tsitoura DC, DeKruyff RH, Lamb JR, Umetsu DT. Intranasal exposure to protein antigen induces immunological tolerance mediated by functionally disabled CD4+ T cells. J Immunol 1999;163:2592-600.
39. Groux H, O'Garra A, Bigler M, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-42.
40. Cottrez F, Hurst SD, Coffman RL, Groux H. T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 2000;165:4848-53.
41. Raz E, Tighe H, Sato Y, et al. Preferential induction of a Thl immune response and inhibition of specific IcE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci 1996;93:5141-5.
42. Hansen G, Yeung VP, Berry G, Umetsu DT, DeKruyff RH. Vaccination with heat killed listeria as adjuvant reverses established allergen-induced airway hyperreactivity and inflammation: role of CD8+ T cells and IL-18. J Immunol 2000;164:223-30.
43. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-40.
44. Weiner HL. The mucosal milieu creates tolerogenic dendritic cells and Tr1 and Th3 regulatory cells. Nat Immunol 2001;2:671-2.
45. Chen W, Jin W, Wahl SM. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor b (TGF-b) production by murine CD4+ T cells. J Exp Med 1998;188:1849-57.
46. McAdam AJ, Greenwald RJ, Levin MA, et al. ICOS is critical for CD40-mediated antibody class switching. Nature 2001;409:102-5.
47. Hutloff A, Dittrich AM, Beier KC, et al. ICOS is an inducible T-cell costimulator structurally and functionally related to CD28. Nature 1999;397:263-6.
48. Fuss IJ, Boirivant M, Lacy B, Strober W. The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis. J Immunol 2002;168:900-8.
49. Gerosa F, Paganin C, Peritt D, et al. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10. J Exp Med 1996:2559-69.